Formulation and Optimization of Trandolapril Oro-dispersible Tablets using the Quality by Design (QbD) Approach

被引:1
|
作者
Kumar, Ganesh [1 ]
Bhatt, Meenakshi [2 ]
机构
[1] Coll Pharm, Shivalik Campus, Dehra Dun, Uttrakhand, India
[2] SGRR Univ, Sch Pharmaceut Sci, Dehra Dun, Uttrakhand, India
关键词
Oro-dispersible tablet; crospovidone; microcrystalline cellulose; quality by design; disintegration; friability; PRODUCTS;
D O I
10.2174/1570180819666220429153102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction This study aims to use a Quality by Design (QbD) approach to formulate and optimize Trandolapriloro-dispersible tablets. The central composite design tool was utilized to assess the scientific understanding of independent input variables and output responses to construct a design space for regulatory flexibility. Oro-dispersible Tablets (ODT) can also be used to deliver drugs directly to the oral mucosa, bypassing first-pass hepatic metabolism and potentially accelerating the process. Methodology The concentrations of super disintegrant and dry compressible binder were selected as independent variables. Disintegration time in seconds and % friability was selected as dependent variables. Polynomial equations were used to predict the quantitative effect of independent variables at various levels on response variables. Results and Discussion The pre-compression parameters suggested that the flow characteristics were quite excellent. All tablets prepared in the above experiments were evaluated for pharmaco-technical properties and found to be within the required limits using the direct compression method. The angle of repose of the dry blends from each formulation batch (F1 to F9) ranged from 29.03 & DEG; to 33.67 & DEG;. All formulation batches had a loose bulk density of 0.31 & PLUSMN; 0.07 to 0.37 & PLUSMN; 0.91 g/cm(3) and a tapped density of 0.41 & PLUSMN; 0.02 to 0.46 & PLUSMN; 0.16 g/cm(3), respectively. The compressibility index was determined to be between 1.65 & PLUSMN; 0.17 to 19.93 & PLUSMN; 0.47 . Hausner's ratio was between 1.14 & PLUSMN; 0.88 to 1.19 & PLUSMN; 0.32. The thickness of the tablets ranged from 2.07 & PLUSMN; 0.54 to 2.52 & PLUSMN; 0.12 mm. The tablets were found to have a hardness of 3.08 & PLUSMN; 0.14 to 3.67 & PLUSMN; 0.41 kg/cm(2). The weight of the tablets prepared ranged from 50 & PLUSMN; 0.09 to 52 & PLUSMN; 0.56 mg on average. Tablet friability was 0.52 & PLUSMN; 0.54 to 0.83 & PLUSMN; 0.10%, and the disintegration time ranged between 27 and 58 seconds. All of these parameters were found under the acceptable limit of pharmacopoeias. The increase of Crospovidone concentration decreased the disintegration time and increased % friability. Whereas increasing the concentration of microcrystalline cellulose increased the disintegration time and decreased the % friability. Contour plots clarified the link between independent and dependent variables. The most cost-effective batch was chosen based on these plots within the desired range because the actual and projected values suggested by the full model were very close to each other; the statistical model is mathematically valid. Conclusion The results showed that the proposed design for developing trandolapriloro-dispersible tablets with optimal properties was effective.
引用
收藏
页码:1194 / 1203
页数:10
相关论文
共 50 条
  • [41] Optimization study on the formulation of roxithromycin dispersible tablet using experimental design
    Kwon -Yeon Weon
    Kyung -Tae Lee
    Sung -Hoon Seo
    Archives of Pharmacal Research, 2000, 23 : 507 - 512
  • [42] Optimization study on the formulation of roxithromycin dispersible tablet using experimental design
    Weon, KY
    Lee, KT
    Seo, SH
    ARCHIVES OF PHARMACAL RESEARCH, 2000, 23 (05) : 507 - 512
  • [43] Developing Alfuzosin Tablet Formulation Based on Quality by Design (QbD) Approach by Using Artificial Neural Network
    Aksu, Buket
    Mesut, Burcu
    Ozsoy, Yildiz
    LATIN AMERICAN JOURNAL OF PHARMACY, 2019, 38 (04): : 668 - 676
  • [44] FORMULATION DEVELOPMENT OF DONEPEZIL HYDROCHLORIDE ORAL DISINTEGRATING TABLETS USING QUALITY BY DESIGN APPROACH
    Patel, Tejas B.
    Patel, Tushar R.
    Suhagia, B. N.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (05): : 2097 - 2108
  • [45] Quality by Design (QbD) Approach for Optimization of Microemulsion based Topical Gel
    Shah, Vidhi
    Gandhi, Krupa
    Parikh, Rajesh
    Sharma, Mukesh
    Suthar, Vrunda
    MARMARA PHARMACEUTICAL JOURNAL, 2016, 20 (03) : 415 - 424
  • [46] Quality by Design (QbD) Aided Formulation Optimization of Amlodipine Besylate Oral Thin Film
    Kumar, Abhiram
    Kumar, Madhaw
    Singh, Romi
    Upadhyay, Pratibha
    Mukherjee, Anubhab
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (02) : s444 - s452
  • [47] Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach
    Castillo Henriquez, Luis
    Vargas Zuniga, Rolando
    Carazo Berrocal, Gustavo
    Madrigal Redondo, German
    Calvo Guzman, Briner
    Baltodano Viales, Eleaneth
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2019, 45 (10) : 1674 - 1681
  • [48] Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach
    Zhang, Jiaxiang
    Thakkar, Rishi
    Zhang, Yu
    Maniruzzaman, Mohammed
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 590
  • [49] Quality by design approach for optimization of repaglinide buccal tablets using Box-Behnken Design
    Navamanisubramanian, Raja
    Nerella, Raghunandan
    Duraipandian, Chamundeeswari
    Seetharaman, Shanmuganathan
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 4 (02) : 265 - 272
  • [50] Formulation Development and Characterization of Darunavir and Ritonavir Sustained Release Tablets Using Quality by Design Approach
    Patel, Dhaval
    Patel, Hitesh
    Chaudhary, Hiren
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (53B) : 159 - 172